Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Valeant CEO agrees to be deposed in Senate drug price probe

The chief executive of Valeant Pharmaceuticals, J. Michael Pearson, has agreed to be deposed by a Senate committee investigating the causes of soaring prescription medicine prices, according to an Associated Press report.

McKesson Corporation Fiscal 2016 Fourth Quarter Conference Call Scheduled for May 4, 2016

SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) will release financial results for its fourth fiscal quarter ended March 31, 2016 on Wednesday, May 4, 2016, following the market close at approximately 4:00 PM Eastern Time (1:00 PM Pacific Time). The company has scheduled a conference call for 5:00 PM Eastern Time (2:00 PM Pacific Time), during which John Hammergren, chairman and chief executive officer, and James Beer, executive vice president and chief financial officer, will review these results.

U.S. drug spending climbs 12 percent in 2015

Total spending on prescription drugs in the U.S. rose 12.2 percent to nearly $425 billion in 2015, continuing a steep climb fueled by the introduction in recent years of expensive new drugs for cancer and infections, as well as price hikes for older drugs, according to The Wall Street Journal.

New study shows rich, poor have huge mortality gap in U.S.

Poverty in the U.S. is often associated with deprivations in housing, employment, and education. Now, a study published by the Journal of American Medicine offers, in unprecedented geographic detail, another stark reality: Poor people live shorter lives, too.

Thumbnail

Study shows 37% of outpatient healthcare staff fail to follow hand hygiene recommendations

Staff at outpatient care facilities may need to brush up on hygiene basics, as a new study found a failure to follow recommendations for hand hygiene in 37 percent of observations.

States poised to take the lead on healthcare cost control

A new report from the Center for American Progress outlines how states are well-positioned to be leaders in implementing policies to help control health care costs and improve quality. 

Zotec Partners to Deliver Three Attendee Experiences at the 2016 EDPMA Solutions Summit

INDIANAPOLIS--(BUSINESS WIRE)--As part of its Gold Sponsorship with The Emergency Department Practice Management Association (EDPMA), Zotec Partners (Zotec), a leading provider of revenue cycle management services for emergency medicine physicians and emergency department practices, announces it will provide guests with three unique experiences during the 2016 EDPMA Solutions Summit.

Report identifies 6 practices to improve healthcare for disadvantaged populations

A new report issued by the National Academies of Sciences, Engineering, and Medicine identifies six promising practices to improve healthcare for individuals in disadvantaged populations.

Displaying 6209 - 6216 of 8454

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.